# Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego

> **NCT03551002** · — · UNKNOWN · sponsor: **University of California, San Diego** · enrollment: 450 (estimated)

## Conditions studied

- Hepatitis C
- Hepatitis C, Chronic
- HIV/AIDS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03551002
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03551002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03551002, "Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03551002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*